Cell MedX Corp

Healthcare US CMXC

NoneUSD
0.00(0%)

Last update at 2025-02-27T19:05:12.954754Z

Day Range

LowHigh

52 Week Range

0.00152772.00

LowHigh

Fundamentals

Previous Close 0.48
Market Cap126.33M
VolumeNone
P/E Ratio-
Dividend Yield-%
EBITDA-0.44651M
Revenue TTM0.00007M
Revenue Per Share TTM-
Gross Profit TTM 0.00048M
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31
Income before tax	-0.49504M	-0.69738M	0.61M	-1.09270M	-0.90598M
Minority interest	-	-	-	-	-
Net income	-0.49504M	-0.69738M	-0.91084M	-1.09270M	-0.90598M
Selling general administrative	0.36M	0.52M	0.27M	0.73M	0.41M
Selling and marketing expenses	-	-	-	-	-
Gross profit	0.00048M	0.00403M	0.00352M	0.09M	-
Reconciled depreciation	0.00000M	0.00114M	0.00243M	0.00185M	0.00058M
Ebit	-0.44766M	-	0.58M	-1.03835M	-0.67021M
Ebitda	-0.44766M	-0.67055M	-0.68015M	-1.06978M	-0.88868M
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-0.15366M	0.07M	0.01M
Operating income	-0.44766M	-0.67169M	0.73M	-1.03835M	-0.67021M
Other operating expenses	-	-	0.00243M	0.00185M	0.00058M
Interest expense	-	-	0.00000M	0.02M	0.02M
Tax provision	-	-	-	-	-
Interest income	-	-	-	-	-
Net interest income	-0.04738M	-0.02569M	-0.03202M	-0.02107M	-0.23577M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-0.04257M	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-	-	-
Total revenue	0.00276M	0.00607M	0.00676M	0.10M	0.00000M
Total operating expenses	0.45M	0.68M	-0.72868M	1.13M	0.67M
Cost of revenue	0.00228M	0.00203M	-0.00324M	0.01M	-
Total other income expense net	-	-	-0.19623M	-0.03328M	-0.23577M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-0.49504M	-0.69738M	0.61M	-1.09270M	-0.90598M
Net income applicable to common shares	-0.49504M	-0.49504M	-0.91084M	-1.09270M	-0.90598M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2024-05-31	2023-05-31	2022-05-31	2021-05-31	2020-05-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-05-31	2023-05-31	2022-05-31	2021-05-31	2020-05-31
Total assets	0.05M	0.10M	0.04M	0.05M	0.16M
Intangible assets	-	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	-	-	-	0.03M	0.06M
Total liab	0.87M	2.49M	2.05M	1.63M	1.68M
Total stockholder equity	-0.82646M	-2.38548M	-2.00903M	-1.57606M	-1.52034M
Deferred long term liab	-	-	-	-	-
Other current liab	-	0.17M	-	0.04M	0.17M
Common stock	-	0.06M	-	0.06M	0.06M
Capital stock	0.30M	0.06M	0.06M	0.06M	0.06M
Retained earnings	-10.29526M	-10.15278M	-9.65774M	-8.96036M	-8.04952M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	-	-	-	-	-
Cash	0.04M	0.10M	0.02M	0.02M	0.05M
Cash and equivalents	-	-	-	-	-
Total current liabilities	0.87M	2.49M	2.05M	1.28M	1.68M
Current deferred revenue	-	-	-	-	-
Net debt	0.27M	0.90M	0.59M	0.32M	0.46M
Short term debt	-	-	-	-	-
Short long term debt	0.31M	1.00M	0.62M	0.34M	0.50M
Short long term debt total	-	-	-	-	-
Other stockholder equity	-	0.43M	-	0.25M	0.49M
Property plant equipment	-	-	-	0.00120M	0.00184M
Total current assets	0.05M	0.10M	0.04M	0.05M	0.16M
Long term investments	-	-	-	-	-
Net tangible assets	-	-2.38548M	-	-1.57606M	-1.52034M
Short term investments	-	-	-	-	-
Net receivables	-	0.00323M	-	0.01M	0.02M
Long term debt	-	-	-	0.34M	0.50M
Inventory	-	-	-	0.00000M	0.05M
Accounts payable	0.29M	0.41M	0.44M	1.28M	0.91M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	0.06M	0.06M
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-8.96036M	-8.04952M
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.00000M	0.00000M	0.00000M	0.00120M	0.00184M
Capital lease obligations	-	-	-	-	-
Long term debt total	-	-	-	0.34M	0.50M

Breakdown	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31
Investments	-	0.00000M	-0.00157M	-0.00246M	-0.00192M
Change to liabilities	-0.01406M	0.00000M	0.19M	-0.01866M	0.47M
Total cashflows from investing activities	-	-	-0.00157M	-0.00246M	-0.00192M
Net borrowings	0.35M	0.35M	0.33M	0.34M	0.36M
Total cash from financing activities	0.35M	0.35M	0.54M	0.92M	0.36M
Change to operating activities	0.12M	0.12M	0.15M	0.00882M	0.02M
Net income	-0.49504M	-0.69738M	-0.91084M	-1.09270M	-0.90598M
Change in cash	0.07M	0.07M	-0.02691M	-0.01188M	0.05M
Begin period cash flow	0.02M	0.02M	0.05M	0.06M	0.00820M
End period cash flow	0.10M	0.02M	0.02M	0.05M	0.06M
Total cash from operating activities	-0.27221M	-0.27221M	-0.56043M	-0.92584M	-0.30754M
Issuance of capital stock	-	-	-	0.49M	-
Depreciation	0.00000M	0.00114M	0.00243M	0.00185M	0.00058M
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	-	0.00000M	0.01M	0.02M	-0.06431M
Change to account receivables	-	-	-	-	-
Sale purchase of stock	-	-	0.21M	0.57M	-
Other cashflows from financing activities	-	-	-	0.00777M	0.00777M
Change to netincome	0.12M	0.12M	0.20M	0.11M	0.24M
Capital expenditures	0.00000M	0.00000M	0.00157M	0.00246M	0.00192M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-0.05325M	0.06M	0.19M
Exchange rate changes	-	-	0.00257M	-0.00020M	-0.00070M
Cash and cash equivalents changes	-	-	-0.02434M	-0.01208M	0.05M
Change in working capital	0.10M	0.14M	0.22M	0.02M	0.36M
Stock based compensation	-	-	-	-	0.00000M
Other non cash items	0.05M	0.06M	0.05M	0.13M	0.24M
Free cash flow	-0.27221M	-0.45059M	-0.56201M	-0.92831M	-0.30946M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
CMXC Cell MedX Corp	- -%	-	-	-	34548.53	-	103692.30	-31.712
ABT Abbott Laboratories	0.02 0.02%	86.99	25.97	17.24	3.57	3.20	3.81	16.75
SYK Stryker Corporation	1.70 0.58%	295.00	44.07	24.94	5.51	6.12	6.05	25.73
MDT Medtronic PLC	4.20 5.69%	77.95	26.60	15.87	3.35	2.08	3.90	14.12
BSX Boston Scientific Corp	0.01 0.02%	47.69	31.49	17.24	4.41	3.65	4.88	19.19

Reports Covered

View All

Profile

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. It also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.

Cell MedX Corp

123 West Nye Lane, Carson City, NV, United States, 89706

844 238 2692
https://cellmedx.com

Key Executives

Name	Title	Year Born
Ms. Yanika Silina C.M.A., CPA	CFO, Treasurer, Corp. Sec. & Director	1978
Mr. Joao da Costa	COO & Director	1964
Mr. Bradley S. Hargreaves	VP of Technology & Operations and Director	1959
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D.	MD & Independent Director	1952
Mr. Dwayne Yaretz	CEO & Director	1961
Mr. David M. Jeffs	President, CEO & Director	1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.